Article information
Full text is only aviable in PDF
References
[1.]
D.M. Mannino, S.A. Buist, T.L. Petty, P.L. Enright, C.S. Redd.
Lung function and mortality in the United Status: data from the First Matinal Health and Nutritional Examination Survey follow-up study.
Thorax, 58 (2003), pp. 388-393
[2.]
P.G.J. Burney, R. Hooper.
Forced vital capacity, airway obstruction and survival in a general population sample from the USA.
Thorax, 66 (2011), pp. 49-54
[3.]
H.M. Lee, H. Le, B.T. Lee, V.A. López, N.D. Wong.
Forced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality.
Eur Respir J, 36 (2010), pp. 1002-1006
[4.]
J.B. Soriano, J. Ancochea, M. Miravitlles, F. García-Río, E. Durán-Tauleria, L. Muñoz, et al.
Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997–2007.
Eur Respir J, 36 (2010), pp. 758-765
[5.]
K. Naberan, C. de la Roza, M. Lamban, E. Gobartt, A. Martín, M. Miravitlles.
Use of spirometry in the diagnosis and treatment of chronic obstructive pulmonary disease in primary care.
Arch Bronconeumol, 42 (2006), pp. 638-644
[6.]
D. Castillo, R. Guayta, J. Giner, F. Burgos, C. Capdevila, J.B. Soriano, FARMAEPOC group, et al.
COPD case finding by spirometry in high-risk customers of urban community pharmacies: a pilot study.
Respir Med, 103 (2009), pp. 839-845
[7.]
R.E. Dales, K.L. Vandemheen, J. Clinch, S.D. Aaron.
Spirometry in the primary care setting: influence on clinical diagnosis and management of airflow obstruction.
Chest, 128 (2005), pp. 2443-2447
[8.]
M. Monteagudo, et al.
Variabilidad en la realización de la espirometría y sus consecuencias en el tratamiento de la EPOC en Atención Primaria.
Archiv. Bronconeumol, 47 (2011), pp. 226-233
[9.]
C. Pellicer, J.J. Soler-Cataluña, A. Andreu, J. Bueso.
Calidad del diagnóstico de la enfermedad pulmonar obstructiva crónica en el ámbito hospitalario.
Arch. Bronconeumol, 46 (2010), pp. 64-69
[10.]
J.J. Soler-Cataluña, M. Calle, B.G. Cosío, J.M. Marín, E. Monsó, I. Alfageme.
Comité de Calidad Asistencial de la SEPAR;Area de Trabajo EPOC de la SEPAR. Estándares de calidad asistencial en la EPOC.
Arch Bronconeumol, 45 (2009), pp. 196-203
[11.]
Peces-Barba G, Barberà JA, Agustí AGN, Casanova C, et al. Guía clínica SEPAR-ALAT de diagnóstico y tratamiento de la EPOC. Available from: http://www.separ.es/publicaciones/normativas.html. Arch Bronconeumol. 2008;44:271–8.
[12.]
R.A. Pauwels, A.S. Buist, P.M. Calverley, C.R. Jenkins, S.S. Hurd, GOLD Scientific Committee.
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.
Am J Respir Crit Care Med, 163 (2001), pp. 1256-1276
[13.]
Telemetric developments in respiratory monitoring. J. Roca, B. Vallespín, F. Burgos. The Buyers’ Guide to Respiratory Care Products, 2008.
Copyright © 2011. Sociedad Española de Neumología y Cirugía Torácica
